160 related articles for article (PubMed ID: 36971774)
1. Generation of a novel monoclonal antibody against inflammatory biomarker S100A8 using hybridoma technology.
Kim JP; Yun H; Kim EJ; Kim YG; Lee CS; Ko BJ; Kim BG; Jeong HJ
Biotechnol Lett; 2023 Jun; 45(5-6):589-600. PubMed ID: 36971774
[TBL] [Abstract][Full Text] [Related]
2. Generation and Application of Monoclonal Antibodies against Porcine S100A8, S100A9, and S100A12 Proteins Using Hybridoma Technology.
Xia P; Ma X; Yan L; Lian S; Li X; Luo Y; Chen Z; Ji X
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256103
[TBL] [Abstract][Full Text] [Related]
3. Expression of soluble recombinant human matrix metalloproteinase 9 and generation of its monoclonal antibody.
Jeong HJ; Kim EJ; Kim JK; Kim YG; Lee CS; Ko BJ; Kim BG
Protein Expr Purif; 2021 Nov; 187():105931. PubMed ID: 34197919
[TBL] [Abstract][Full Text] [Related]
4. Hybridoma Technology.
Hnasko RM; Stanker LH
Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen Y; Wang Y; Jiang X; Lu L; Wang C; Luo W; Zhang Y; Li P; Du Z; Dai T; Wu C; Fang A; Yao Y; Peng Q; Yang J
Protein Expr Purif; 2018 Jan; 141():44-51. PubMed ID: 28928083
[TBL] [Abstract][Full Text] [Related]
6. Rapid, simple, and effective strategy to produce monoclonal antibodies targeting protein structures using hybridoma technology.
Sakaguchi A; Tanaka Y; Shoji E; Takeshima T; Sakamaki R; Matsuba T; Kurihara Y
J Biol Eng; 2023 Mar; 17(1):24. PubMed ID: 36997993
[TBL] [Abstract][Full Text] [Related]
7. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
8. Antibodies and Selection of Monoclonal Antibodies.
Hanack K; Messerschmidt K; Listek M
Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
[TBL] [Abstract][Full Text] [Related]
9. Hybridoma-free generation of monoclonal antibodies.
Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):257-9. PubMed ID: 14688405
[TBL] [Abstract][Full Text] [Related]
10. [The Role of Calcium in the Conformational Changes of the Recombinant S100A8/S100A9].
Gheibi N; Asghari H; Chegini KG; Sahmani M; Moghadasi M
Mol Biol (Mosk); 2016; 50(1):136-42. PubMed ID: 27028819
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of the monoclonal antibody against human Bocavirus VP2 protein].
Zhao ZH; Xue PH; Wei JM; Zhang Q; Zheng WZ; Ma FL; Yuan WM; Zheng LS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):63-5. PubMed ID: 22919759
[TBL] [Abstract][Full Text] [Related]
12. Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis.
Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
Int J Cancer; 2019 Jul; 145(2):569-575. PubMed ID: 30414170
[TBL] [Abstract][Full Text] [Related]
13. Hybridoma technology; advancements, clinical significance, and future aspects.
Mitra S; Tomar PC
J Genet Eng Biotechnol; 2021 Oct; 19(1):159. PubMed ID: 34661773
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of monoclonal antibody against recombinant human interferon-β1a].
Zhang D; LA W; Li L; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Nov; 31(11):1549-53. PubMed ID: 26522367
[TBL] [Abstract][Full Text] [Related]
15. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics.
Kulshreshtha P; Tiwari A; Priyanka ; Joon S; Sinha S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):185-93. PubMed ID: 26364143
[TBL] [Abstract][Full Text] [Related]
16. Hybridomas producing hemolytic plaques used to study the relationship between monoclonal antibody affinity and the efficiency of plaque inhibition with increasing concentrations of antigen.
Bankert RB; Mazzaferro D; Mayers GL
Hybridoma; 1981; 1(1):47-58. PubMed ID: 6765319
[TBL] [Abstract][Full Text] [Related]
17. Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.
Sarina N; Abeldenov S; Turgimbayeva A; Zhylkibayev A; Ramankulov Y; Khassenov B; Eskendirova S
Hum Antibodies; 2018 Feb; 26(2):103-111. PubMed ID: 29036807
[TBL] [Abstract][Full Text] [Related]
18. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.
Yang JL; Liu DX; Zhen SJ; Zhou YG; Zhang DJ; Yang LY; Chen HB; Feng Q
BMC Cancer; 2016 Feb; 16():131. PubMed ID: 26897358
[TBL] [Abstract][Full Text] [Related]
19. [Research progress in the rapid preparation of monoclonal antibodies of mouse hybridoma].
Fang S; Liu C; Ma J; Yan S; Xu D; Liu Q
Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2293-2306. PubMed ID: 34327896
[TBL] [Abstract][Full Text] [Related]
20. [Preparation antibodies against recombinant bovine IFN-gamma and development of sandwich ELISA for bovine IFN-gamma detection].
Li C; Tan YD; Chen YY; Hu QY; Yan ZG; Qin B; Chao YJ; Chen HC; Guo AZ
Sheng Wu Gong Cheng Xue Bao; 2007 Jan; 23(1):40-5. PubMed ID: 17366886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
